Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07561567

Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device

The purpose of this clinical trial is to understand the safety and effectiveness of abdominal pressure devices in inhibiting respiratory movement in lung cancer patients. The main question it aims to answer is:

Did the abdominal pressure device reduce the respiratory movement of participants with lung cancer tumors?

Participants will:

Record how much they use abdominal pressure devices to suppress lung cancer tumor respiratory movement

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lung Cancer, Non-small Cell Bronchial Neoplasms Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Tianjin Medical University Cancer Institute and Hospital

Tianjin, China

Location status: Recruiting

Location contact

Xu Yao Yu

CONTACT

[email protected]

+862223340123

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis is solitary peripheral lung cancer, and after comprehensive evaluation by the participating physicians based on the patient's clinical data, it is suitable for receiving SBRT treatment;

Exclusion criteria

Central or super central lung cancer patients who are intolerant or unwilling to undergo respiratory suppression and chest and abdominal compression fixation

Treatment and study plan

Chest and abdominal compression

Device

Abdominal compression suppresses respiratory movement in patients

breathing management

Device

Apply pressure to the patient's abdomen to achieve respiratory movement inhibition

Primary outcomes

  1. Tumor displacement range

    Time frame: Within 6 months after enrollment

    Based on 4DCT for delineating tumor motion range and extracting radiomics features in patients with and without respiratory management

Study contacts

Contact information is provided by the study sponsor or research team.

Xuyao Yu Dr

CONTACT

[email protected]

86-022-23341405

Sponsors and collaborators

Lead sponsor

Tianjin Medical University Cancer Institute and Hospital

Other

Registry information

Official study title

A Single Center, Translational Study on the Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Patients Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device

Acronym: E20241186

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 1, 2026
Registry last updated
May 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.